JP2021518748A5 - - Google Patents
Info
- Publication number
- JP2021518748A5 JP2021518748A5 JP2020544204A JP2020544204A JP2021518748A5 JP 2021518748 A5 JP2021518748 A5 JP 2021518748A5 JP 2020544204 A JP2020544204 A JP 2020544204A JP 2020544204 A JP2020544204 A JP 2020544204A JP 2021518748 A5 JP2021518748 A5 JP 2021518748A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- seq
- antibody
- substantially similar
- heavy chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862634643P | 2018-02-23 | 2018-02-23 | |
| US62/634,643 | 2018-02-23 | ||
| PCT/US2019/019319 WO2019165326A1 (en) | 2018-02-23 | 2019-02-23 | Calcitonin gene-related peptide (cgrp) antagonist antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021518748A JP2021518748A (ja) | 2021-08-05 |
| JP2021518748A5 true JP2021518748A5 (https=) | 2022-02-25 |
Family
ID=67688456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020544204A Pending JP2021518748A (ja) | 2018-02-23 | 2019-02-23 | カルシトニン遺伝子関連ペプチド（ｃｇｒｐ）アンタゴニスト抗体 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US11629184B2 (https=) |
| EP (1) | EP3755327A4 (https=) |
| JP (1) | JP2021518748A (https=) |
| CN (1) | CN112040949A (https=) |
| WO (1) | WO2019165326A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023051786A1 (zh) * | 2021-09-30 | 2023-04-06 | 江苏恒瑞医药股份有限公司 | 特异性结合cgrp和pacap的抗原结合分子及其医药用途 |
| EP4570913A1 (en) * | 2022-08-11 | 2025-06-18 | Shanghai Junshi Biosciences Co., Ltd. | Anti-cgrp antibody and use |
| CN118271438B (zh) * | 2024-05-27 | 2024-08-30 | 上海宏成药业有限公司 | 抗cgrp抗体或其抗原结合片段及其用途 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3069731A1 (en) * | 2005-11-14 | 2016-09-21 | Labrys Biologics Inc. | Antagonist antibodies directed against calcitonin gene-related peptide and methods using same |
| WO2007076336A1 (en) * | 2005-12-22 | 2007-07-05 | Eli Lilly And Company | Treatment of migraine with anti-cgrp antibodies |
| WO2008063898A2 (en) * | 2006-11-08 | 2008-05-29 | Kalobios Pharmaceuticals, Inc. | Methods of treating idiopathic thrombocytopenia purpura using a gm-csf antagonist |
| CN101965365A (zh) * | 2007-10-19 | 2011-02-02 | 伊缪纳斯制药株式会社 | 能够特异性结合Aβ寡聚体的抗体及其应用 |
| TWI516501B (zh) | 2008-09-12 | 2016-01-11 | 禮納特神經系統科學公司 | Ｐｃｓｋ９拮抗劑類 |
| WO2011075789A1 (en) * | 2009-12-24 | 2011-06-30 | Biosceptre International Limited | Antibodies to non-functional oligomeric p2x7 receptors |
| TWI622402B (zh) * | 2010-02-24 | 2018-05-01 | 免疫遺傳股份有限公司 | 葉酸受體１抗體類和免疫共軛物類及彼等之用途 |
| PE20141787A1 (es) * | 2011-05-20 | 2014-12-07 | Alderbio Holdings Llc | Composiciones anti-cgrp y uso de las mismas |
| EP2906596B1 (en) * | 2012-10-12 | 2023-12-27 | Arizona Board of Regents on behalf of Arizona State University | Antibody based reagents that specifically recognize toxic oligomeric forms of tau |
| US9629801B2 (en) * | 2014-01-10 | 2017-04-25 | Wisconsin Alumni Research Foundation | Blood-brain barrier targeting antibodies |
| WO2015199618A1 (en) * | 2014-06-24 | 2015-12-30 | National University Of Singapore | Epstein-barr virus lmp2 specific antibody and uses thereof |
| EP3200822B1 (en) * | 2014-09-30 | 2021-04-14 | Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts | Binding molecules, especially antibodies, binding to l1cam (cd171) |
| MX2018014950A (es) * | 2016-06-07 | 2019-04-25 | Macrogenics Inc | Terapia de combinacion. |
-
2019
- 2019-02-23 JP JP2020544204A patent/JP2021518748A/ja active Pending
- 2019-02-23 CN CN201980027708.7A patent/CN112040949A/zh active Pending
- 2019-02-23 US US16/975,120 patent/US11629184B2/en active Active
- 2019-02-23 EP EP19756784.5A patent/EP3755327A4/en not_active Withdrawn
- 2019-02-23 WO PCT/US2019/019319 patent/WO2019165326A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020508655A5 (https=) | ||
| JP2021191763A5 (https=) | ||
| JP7257971B2 (ja) | 抗ｃｄ４０抗体、その抗原結合フラグメント、およびその医学的使用 | |
| JP2019532619A5 (https=) | ||
| JP2020514277A5 (https=) | ||
| JP2018522888A5 (https=) | ||
| RU2019121086A (ru) | Иммунотерапия с применением антител, связывающих лиганд 1 белка программируемой смерти клеток (PD-L1) | |
| HRP20120701T1 (hr) | Humana monoklonska protutijela protiv fukozil-gm1 i postupci za uporabu antifukozil-gm1 | |
| IL295295A (en) | Antibodies targeting fc receptor-like 5 and methods of use | |
| JP2023551027A5 (https=) | ||
| JP2022549172A5 (https=) | ||
| JP2010538608A5 (https=) | ||
| JP2024527288A5 (https=) | ||
| WO2022121980A1 (zh) | 抗SIRPα抗体及其用途 | |
| JP2021511387A5 (https=) | ||
| JP2022533538A5 (https=) | ||
| JP2024516595A5 (https=) | ||
| JP2020513759A5 (https=) | ||
| JP2024532489A5 (https=) | ||
| RU2019121106A (ru) | Иммунотерапия с применением антител, связывающих белок 1 программируемой смерти клеток (pd-1) | |
| JP2020502233A5 (https=) | ||
| JP2021512604A5 (https=) | ||
| JP2022542574A5 (https=) | ||
| JP2023520969A5 (https=) | ||
| JP2019505477A5 (https=) |